Operates a federated network providing real-world health data and analytics for clinical trials and life sciences research.
Founded in 2013 and headquartered in Cambridge, US, TriNetX, LLC provides a self-service platform with de-identified electronic health record datasets and analytics. Clients include pharmaceutical companies, healthcare providers and academic institutions in North America, Europe and Asia-Pacific, and the tools support trial protocol design, trial operations and pharmacovigilance. CEO Gadi Lachman leads the company, which has completed 5 investment deals. Carlyle Group acquired a majority stake on September 21, 2020, for an undisclosed amount.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in